Trade Setup for Thursday: Top 15 things to know before Opening Bell Key support level for Nifty is placed at 12067.1, followed by 12008.3. If the index continues moving up, key resistance levels to watch out for are 12159.7 and 12193.5.
J B Chemicals gets EIR from USFDA for unit in Gujarat The company has received EIR from the United States Food and Drug Administration (US FDA) for its newly set up and commissioned solid oral dosage forms formulations manufacturing facility at Panoli, Gujarat, J B Chemicals and Pharmaceuticals said in a regulatory filing.
Ranitidine recall forces GSK to alter Indian market strategy GSK had initiated global voluntary recall of Ranitidine in September 2019, following reports of a probable cancer causing impurity called N‐nitrosodimethylamine (NDMA).
JB Chemicals Gujarat unit passes USFDA inspection with one observation The company's solid oral dosage forms formulations manufacturing facility at Panoli, Gujarat, has successfully passed periodical inspection by USFDA with one minor procedural observation, JB Chemicals and Pharmaceuticals said in a filing to BSE.
Buy J B Chemicals & Pharmaceuticals Ltd For Target Rs.550 - ANGEL BROKING LTD
National Pharmaceuticals Pricing Authority (NPPA) has notified one-time price increase of 50% from existing ceiling price in case of 21 drugs. This is in view of public interest to avoid shortage of t...
ICICI Securities sees Nifty at 13,400 in next one year; L&T, NMDC among top 10 picks ICICI Securities, in a recent note, maintained its one-year target for the Nifty at 13,400, which translates into an upside of 20 percent from current levels.
Manufacturers say Rantac safe for consumption, NDMA within permissible limits Earlier this week on September 23, the Drug Controller General of India (DCGI) asked state regulators to direct manufacturers of Ranitidine API to take measures to verify their products for the presence of NDMA, in order to ensure safety of consumers/patients.
GSK suspends Ranitidine distribution in India, regulators seek drug testing data from pharma cos Sources within pharma industry told Moneycontrol that Dr Reddy’s and Saraca Laboratories are two big suppliers of the Ranitidine active pharmaceutical ingredient (API) globally, from which most other companies source the API to formulate the drug.
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.